Erratum: TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin

Elena A Feshchenko^1,4, Evgeniya V Smirnova¹, Gayathri Swaminathan¹, Anjali M Teckchandani¹, Rachana Agrawal¹, Hamid Band^2,5, Xiaolong Zhang^3,6, Roland S Annan³, Steven A Carr^3,7, Alexander Y Tsygankov^*,1

Correction to: Oncogene (2004) 23, 4690–4706. doi: 10.1038/sj.onc.1207627

Due to a typesetting error, the author affiliations were published incorrectly. The correct details are as below.

¹Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA, USA

²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

³Glaxo-SmithKline, King of Prussia, PA, USA

⁴Current address: Curagen, Branford, CT, USA

⁵Current address: Feinberg School of Medicine, Northwestern University, Evanston, IL, USA

⁶Current address: Celera Genomics, Rockville, MD, USA

⁷Current address: Millennium Pharmaceuticals, Cambridge, MA, USA

^*Correspondence: AY Tsygankov, Department of Microbiology and Immunology, Temple University School of Medicine, 3400 N Broad Street, Philadelphia, PA 19140, USA. E-mail: alexander.tsygankov@temple.edu